Genflow Biosciences PLC

GENF

Company Profile

  • Business description

    Genflow Biosciences PLC is a preclinical biotechnology company focused on developing biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process, and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

  • Contact

    6 Heddon Street
    LondonW1B 4BT
    GBR

    T: +44 2081425409

    E: [email protected]

    https://www.genflowbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    5

Stocks News & Analysis

stocks

A collection of our best stock opportunities

Our latest articles about where we see opportunities in the market.
stocks

Morningstar analyst reacts to Macquarie Group’s earnings

Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks

Undervalued ASX share showing progress in global efforts

More clarity on the path forward in the UK.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,963.5029.200.33%
CAC 407,800.8833.70-0.43%
DAX 4023,970.36247.14-1.02%
Dow JONES (US)44,762.98138.94-0.31%
FTSE 1009,081.4438.87-0.43%
HKSE25,562.13173.780.68%
NASDAQ21,139.2030.880.15%
Nikkei 22540,998.27457.96-1.10%
NZX 50 Index12,910.7457.280.45%
S&P 5006,378.2810.36-0.16%
S&P/ASX 2008,697.7030.800.36%
SSE Composite Index3,597.944.280.12%

Market Movers